Course: Even Partial COVID-19 Vaccination Protects Nursing Home Residents
CME Credits: 1.00
Released: 2021-05-11
A CDC has shown that a single dose of the Pfizer-BioNTech COVID-19 vaccine protected medically vulnerable nursing home residents as well as it did general adult populations that were evaluated in other efficacy and effectiveness studies.
The analysis helps fill a data gap about vaccine effectiveness in this high-risk group—generally older, frail adults with underlying health conditions—who were left out of COVID-19 vaccine trials. older adults from the trials raised questions about how well nursing home residents would respond to vaccination.
Educational Objective
To identify the key insights or developments described in this article
View Full Course